Additionally, POL has been shown to effectively attenuate DSS-induced colitis by inhibiting oxidative stress responses, such as nitric oxide and superoxide dismutase, as well as reducing the levels of pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 [27–29]. This evidence concerns the gene IL6 and colitis.